A phase II dose-response study of hemoglobin raffimer (Hemolink) in elective coronary artery bypass surgery

Davy C.H. Cheng, C. D. Mazer, R. Martineau, A. Ralph-Edwards, J. Karski, J. Robblee, B. Finegan, R. I. Hall, R. Latimer, A. Vuylsteke

Research output: Contribution to journal › Article › peer-review